Clinical trial
Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis…
NCT00195702 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00195702 |
|---|---|
| Title | Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate. |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Rheumatoid Arthritis Patients Currently Receiving Treatment With Methotrexate |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Biological, Drug |
| Interventions | Adalimumab, Placebo |
| Enrollment | 619 |
| Start date | Feb 1, 2000 |
| Primary completion | Sep 1, 2002 |
| Completion | Aug 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 26, 2011 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: